Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas

The human epidermal growth factor receptor 2 (HER2) represents one of the most studied tumor-associated antigens for cancer immunotherapy. The receptors for HER2 are overexpressed in various human cancers, such as breast and ovarian cancer. The relatively low expression of this antigen on normal tis...

Descripción completa

Detalles Bibliográficos
Autores principales: Okarvi, Subhani M., AlJammaz, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749314/
https://www.ncbi.nlm.nih.gov/pubmed/31470531
http://dx.doi.org/10.3390/molecules24173142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6749314/
https://www.ncbi.nlm.nih.gov/pubmed/31470531
http://dx.doi.org/10.3390/molecules24173142

Ejemplares similares